PubMed:9790667
Annnotations
NCBI-Disease-Corpus-GPT5-withguidelines
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 269-299 | SpecificDisease | denotes | cerebrotendinous xanthomatosis |
| T2 | 301-304 | SpecificDisease | denotes | CTX |
| T3 | 438-486 | SpecificDisease | denotes | deficiency in the sterol 27-hydroxylase activity |
| T4 | 1365-1413 | SpecificDisease | denotes | deficiency in the sterol 27-hydroxylase activity |
NCBI-Disease-Corpus-GPT5-noguidelines
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 269-305 | SpecificDisease | denotes | cerebrotendinous xanthomatosis (CTX) |
NCBI-Disease-Corpus-GPT5-guidelineprompt
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 269-299 | SpecificDisease | denotes | cerebrotendinous xanthomatosis |
| T2 | 301-304 | SpecificDisease | denotes | CTX |
NCBI-Disease-Corpus-Moderated1
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 269-299 | SpecificDisease | denotes | cerebrotendinous xanthomatosis |
| T2 | 301-304 | SpecificDisease | denotes | CTX |
| T3 | 438-486 | DiseaseClass | denotes | deficiency in the sterol 27-hydroxylase activity |
| T4 | 1365-1413 | DiseaseClass | denotes | deficiency in the sterol 27-hydroxylase activity |
sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| TextSentencer_T1 | 0-123 | Sentence | denotes | A novel Arg362Ser mutation in the sterol 27-hydroxylase gene (CYP27): its effects on pre-mRNA splicing and enzyme activity. |
| TextSentencer_T2 | 124-306 | Sentence | denotes | A novel C to A mutation in the sterol 27-hydroxylase gene (CYP27) was identified by sequencing amplified CYP27 gene products from a patient with cerebrotendinous xanthomatosis (CTX). |
| TextSentencer_T3 | 307-547 | Sentence | denotes | The mutation changed the adrenodoxin cofactor binding residue 362Arg to 362Ser (CGT 362Arg to AGT 362Ser), and was responsible for deficiency in the sterol 27-hydroxylase activity, as confirmed by expression of mutant cDNA into COS-1 cells. |
| TextSentencer_T4 | 548-669 | Sentence | denotes | Quantitative analysis showed that the expression of CYP27 gene mRNA in the patient represented 52.5% of the normal level. |
| TextSentencer_T5 | 670-985 | Sentence | denotes | As the mutation occurred at the penultimate nucleotide of exon 6 (-2 position of exon 6-intron 6 splice site) of the gene, we hypothesized that the mutation may partially affect the normal splicing efficiency in exon 6 and cause alternative splicing elsewhere, which resulted in decreased transcript in the patient. |
| TextSentencer_T6 | 986-1244 | Sentence | denotes | Transfection of constructed minigenes, with or without the mutation, into COS-1 cells confirmed that the mutant minigene was responsible for a mRNA species alternatively spliced at an activated cryptic 5' splice site 88 bp upstream from the 3' end of exon 6. |
| TextSentencer_T7 | 1245-1485 | Sentence | denotes | Our data suggest that the C to A mutation at the penultimate nucleotide of exon 6 of the CYP27 gene not only causes the deficiency in the sterol 27-hydroxylase activity, but also partially leads to alternative pre-mRNA splicing of the gene. |
| TextSentencer_T8 | 1486-1621 | Sentence | denotes | To our knowledge, this is the first report regarding effects on pre-mRNA splicing of a mutation at the -2 position of a 5' splice site. |
| T1 | 0-123 | Sentence | denotes | A novel Arg362Ser mutation in the sterol 27-hydroxylase gene (CYP27): its effects on pre-mRNA splicing and enzyme activity. |
| T2 | 124-306 | Sentence | denotes | A novel C to A mutation in the sterol 27-hydroxylase gene (CYP27) was identified by sequencing amplified CYP27 gene products from a patient with cerebrotendinous xanthomatosis (CTX). |
| T3 | 307-547 | Sentence | denotes | The mutation changed the adrenodoxin cofactor binding residue 362Arg to 362Ser (CGT 362Arg to AGT 362Ser), and was responsible for deficiency in the sterol 27-hydroxylase activity, as confirmed by expression of mutant cDNA into COS-1 cells. |
| T4 | 548-669 | Sentence | denotes | Quantitative analysis showed that the expression of CYP27 gene mRNA in the patient represented 52.5% of the normal level. |
| T5 | 670-985 | Sentence | denotes | As the mutation occurred at the penultimate nucleotide of exon 6 (-2 position of exon 6-intron 6 splice site) of the gene, we hypothesized that the mutation may partially affect the normal splicing efficiency in exon 6 and cause alternative splicing elsewhere, which resulted in decreased transcript in the patient. |
| T6 | 986-1244 | Sentence | denotes | Transfection of constructed minigenes, with or without the mutation, into COS-1 cells confirmed that the mutant minigene was responsible for a mRNA species alternatively spliced at an activated cryptic 5' splice site 88 bp upstream from the 3' end of exon 6. |
| T7 | 1245-1485 | Sentence | denotes | Our data suggest that the C to A mutation at the penultimate nucleotide of exon 6 of the CYP27 gene not only causes the deficiency in the sterol 27-hydroxylase activity, but also partially leads to alternative pre-mRNA splicing of the gene. |
| T8 | 1486-1621 | Sentence | denotes | To our knowledge, this is the first report regarding effects on pre-mRNA splicing of a mutation at the -2 position of a 5' splice site. |
DisGeNET
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T0 | 155-176 | gene:1593 | denotes | sterol 27-hydroxylase |
| T1 | 269-299 | disease:C0238052 | denotes | cerebrotendinous xanthomatosis |
| T2 | 155-176 | gene:1593 | denotes | sterol 27-hydroxylase |
| T3 | 301-304 | disease:C0238052 | denotes | CTX |
| T4 | 183-188 | gene:1593 | denotes | CYP27 |
| T5 | 269-299 | disease:C0238052 | denotes | cerebrotendinous xanthomatosis |
| T6 | 183-188 | gene:1593 | denotes | CYP27 |
| T7 | 301-304 | disease:C0238052 | denotes | CTX |
| T8 | 229-234 | gene:1593 | denotes | CYP27 |
| T9 | 269-299 | disease:C0238052 | denotes | cerebrotendinous xanthomatosis |
| T10 | 229-234 | gene:1593 | denotes | CYP27 |
| T11 | 301-304 | disease:C0238052 | denotes | CTX |
| R1 | T0 | T1 | associated_with | sterol 27-hydroxylase,cerebrotendinous xanthomatosis |
| R2 | T2 | T3 | associated_with | sterol 27-hydroxylase,CTX |
| R3 | T4 | T5 | associated_with | CYP27,cerebrotendinous xanthomatosis |
| R4 | T6 | T7 | associated_with | CYP27,CTX |
| R5 | T8 | T9 | associated_with | CYP27,cerebrotendinous xanthomatosis |
| R6 | T10 | T11 | associated_with | CYP27,CTX |
DisGeNET5_gene_disease
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| 9790667-1#31#52#gene1593 | 155-176 | gene1593 | denotes | sterol 27-hydroxylase |
| 9790667-1#59#64#gene1593 | 183-188 | gene1593 | denotes | CYP27 |
| 9790667-1#105#110#gene1593 | 229-234 | gene1593 | denotes | CYP27 |
| 9790667-1#145#175#diseaseC0238052 | 269-299 | diseaseC0238052 | denotes | cerebrotendinous xanthomatosis |
| 9790667-1#177#180#diseaseC0238052 | 301-304 | diseaseC0238052 | denotes | CTX |
| 9790667-1#145#175#diseaseC0238052 | 269-299 | diseaseC0238052 | denotes | cerebrotendinous xanthomatosis |
| 9790667-1#177#180#diseaseC0238052 | 301-304 | diseaseC0238052 | denotes | CTX |
| 9790667-1#145#175#diseaseC0238052 | 269-299 | diseaseC0238052 | denotes | cerebrotendinous xanthomatosis |
| 9790667-1#177#180#diseaseC0238052 | 301-304 | diseaseC0238052 | denotes | CTX |
| 31#52#gene1593145#175#diseaseC0238052 | 9790667-1#31#52#gene1593 | 9790667-1#145#175#diseaseC0238052 | associated_with | sterol 27-hydroxylase,cerebrotendinous xanthomatosis |
| 31#52#gene1593177#180#diseaseC0238052 | 9790667-1#31#52#gene1593 | 9790667-1#177#180#diseaseC0238052 | associated_with | sterol 27-hydroxylase,CTX |
| 31#52#gene1593145#175#diseaseC0238052 | 9790667-1#31#52#gene1593 | 9790667-1#145#175#diseaseC0238052 | associated_with | sterol 27-hydroxylase,cerebrotendinous xanthomatosis |
| 31#52#gene1593177#180#diseaseC0238052 | 9790667-1#31#52#gene1593 | 9790667-1#177#180#diseaseC0238052 | associated_with | sterol 27-hydroxylase,CTX |
| 31#52#gene1593145#175#diseaseC0238052 | 9790667-1#31#52#gene1593 | 9790667-1#145#175#diseaseC0238052 | associated_with | sterol 27-hydroxylase,cerebrotendinous xanthomatosis |
| 31#52#gene1593177#180#diseaseC0238052 | 9790667-1#31#52#gene1593 | 9790667-1#177#180#diseaseC0238052 | associated_with | sterol 27-hydroxylase,CTX |
| 59#64#gene1593145#175#diseaseC0238052 | 9790667-1#59#64#gene1593 | 9790667-1#145#175#diseaseC0238052 | associated_with | CYP27,cerebrotendinous xanthomatosis |
| 59#64#gene1593177#180#diseaseC0238052 | 9790667-1#59#64#gene1593 | 9790667-1#177#180#diseaseC0238052 | associated_with | CYP27,CTX |
| 59#64#gene1593145#175#diseaseC0238052 | 9790667-1#59#64#gene1593 | 9790667-1#145#175#diseaseC0238052 | associated_with | CYP27,cerebrotendinous xanthomatosis |
| 59#64#gene1593177#180#diseaseC0238052 | 9790667-1#59#64#gene1593 | 9790667-1#177#180#diseaseC0238052 | associated_with | CYP27,CTX |
| 59#64#gene1593145#175#diseaseC0238052 | 9790667-1#59#64#gene1593 | 9790667-1#145#175#diseaseC0238052 | associated_with | CYP27,cerebrotendinous xanthomatosis |
| 59#64#gene1593177#180#diseaseC0238052 | 9790667-1#59#64#gene1593 | 9790667-1#177#180#diseaseC0238052 | associated_with | CYP27,CTX |
| 105#110#gene1593145#175#diseaseC0238052 | 9790667-1#105#110#gene1593 | 9790667-1#145#175#diseaseC0238052 | associated_with | CYP27,cerebrotendinous xanthomatosis |
| 105#110#gene1593177#180#diseaseC0238052 | 9790667-1#105#110#gene1593 | 9790667-1#177#180#diseaseC0238052 | associated_with | CYP27,CTX |
| 105#110#gene1593145#175#diseaseC0238052 | 9790667-1#105#110#gene1593 | 9790667-1#145#175#diseaseC0238052 | associated_with | CYP27,cerebrotendinous xanthomatosis |
| 105#110#gene1593177#180#diseaseC0238052 | 9790667-1#105#110#gene1593 | 9790667-1#177#180#diseaseC0238052 | associated_with | CYP27,CTX |
| 105#110#gene1593145#175#diseaseC0238052 | 9790667-1#105#110#gene1593 | 9790667-1#145#175#diseaseC0238052 | associated_with | CYP27,cerebrotendinous xanthomatosis |
| 105#110#gene1593177#180#diseaseC0238052 | 9790667-1#105#110#gene1593 | 9790667-1#177#180#diseaseC0238052 | associated_with | CYP27,CTX |
PubCasesHPO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| AB1 | 286-299 | HP:0000991 | denotes | xanthomatosis |
PubCasesORDO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| AB1 | 269-299 | ORDO:909 | denotes | cerebrotendinous xanthomatosis |
| AB2 | 301-304 | ORDO:909 | denotes | CTX |
NCBIDiseaseCorpus
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 269-299 | SpecificDisease:D019294 | denotes | cerebrotendinous xanthomatosis |
| T2 | 301-304 | SpecificDisease:D019294 | denotes | CTX |
| T3 | 1365-1413 | SpecificDisease:D019294 | denotes | deficiency in the sterol 27-hydroxylase activity |
NCBI-Disease-Test
| Id | Subject | Object | Predicate | Lexical cue | database_id |
|---|---|---|---|---|---|
| T178 | 269-299 | SpecificDisease | denotes | cerebrotendinous xanthomatosis | D019294 |
| T179 | 301-304 | SpecificDisease | denotes | CTX | D019294 |
| T180 | 1365-1413 | SpecificDisease | denotes | deficiency in the sterol 27-hydroxylase activity | D019294 |
NCBI-Disease-Test-Assistant-Knowledge
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 269-305 | SpecificDisease | denotes | cerebrotendinous xanthomatosis (CTX) |
| T2 | 456-486 | SpecificDisease | denotes | sterol 27-hydroxylase activity |
| T3 | 1383-1413 | SpecificDisease | denotes | sterol 27-hydroxylase activity |
NCBI-Disease-Test-4o-NoGuidelineInPrompt
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 269-299 | SpecificDisease | denotes | cerebrotendinous xanthomatosis |
| T2 | 301-304 | CompositeMention | denotes | CTX |
| T3 | 456-477 | Modifier | denotes | sterol 27-hydroxylase |
| T4 | 1383-1404 | Modifier | denotes | sterol 27-hydroxylase |
NCBI-Disease-Corpus-o3-2
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 269-299 | SpecificDisease | denotes | cerebrotendinous xanthomatosis |
| T2 | 301-304 | SpecificDisease | denotes | CTX |
NCBI-Disease-Corpus-high-o3-1
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 269-299 | SpecificDisease | denotes | cerebrotendinous xanthomatosis |
| T2 | 301-304 | SpecificDisease | denotes | CTX |
NCBI-Disease-Corpus-high-o3-2
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 269-299 | SpecificDisease | denotes | cerebrotendinous xanthomatosis |
| T2 | 301-304 | SpecificDisease | denotes | CTX |
NCBI-Disease-Test-4o-GuidelineInPrompt
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 269-299 | SpecificDisease | denotes | cerebrotendinous xanthomatosis |
NCBI-Disease-Corpus-UpdatedGuideline
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 269-299 | SpecificDisease | denotes | cerebrotendinous xanthomatosis |
NCBI-Disease-Corpus-humanintheloop
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 269-299 | SpecificDisease | denotes | cerebrotendinous xanthomatosis |
| T2 | 301-304 | SpecificDisease | denotes | CTX |
| T3 | 456-477 | Modifier | denotes | sterol 27-hydroxylase |
| T4 | 1383-1404 | Modifier | denotes | sterol 27-hydroxylase |
NCBI-Disease-Corpus-rezarta1
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 269-299 | SpecificDisease | denotes | cerebrotendinous xanthomatosis |
| T2 | 301-304 | SpecificDisease | denotes | CTX |
NCBI-Disease-Corpus-All
| Id | Subject | Object | Predicate | Lexical cue | database_id |
|---|---|---|---|---|---|
| T178 | 269-299 | SpecificDisease | denotes | cerebrotendinous xanthomatosis | D019294 |
| T179 | 301-304 | SpecificDisease | denotes | CTX | D019294 |
| T180 | 1365-1413 | SpecificDisease | denotes | deficiency in the sterol 27-hydroxylase activity | D019294 |
NCBI-Disease-Corpus-2stage-All
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 269-299 | SpecificDisease | denotes | cerebrotendinous xanthomatosis |
| T2 | 301-304 | SpecificDisease | denotes | CTX |
NCBI-Disease-Corpus-rezarta-All
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 269-299 | SpecificDisease | denotes | cerebrotendinous xanthomatosis |
NCBI-Disease-Corpus-4oGuideline-All
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 269-299 | SpecificDisease | denotes | cerebrotendinous xanthomatosis |
NCBI-Disease-Corpus-Simple-All
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 269-305 | SpecificDisease | denotes | cerebrotendinous xanthomatosis (CTX) |
123456
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 269-299 | SpecificDisease | denotes | cerebrotendinous xanthomatosis |
| T2 | 301-304 | SpecificDisease | denotes | CTX |
| T3 | 456-477 | Modifier | denotes | sterol 27-hydroxylase |
| T4 | 1383-1404 | Modifier | denotes | sterol 27-hydroxylase |
12345
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 269-299 | SpecificDisease | denotes | cerebrotendinous xanthomatosis |
| T2 | 301-304 | SpecificDisease | denotes | CTX |
| T3 | 456-477 | Modifier | denotes | sterol 27-hydroxylase |
| T4 | 1383-1404 | Modifier | denotes | sterol 27-hydroxylase |